期刊文献+

Cyclin E表达失调导致人类结肠癌染色体不稳定

Deregulation of Cyclin E induces chromosomal instability in human colon cancer
下载PDF
导出
摘要 目的:研究Cyclin E的表达失调对人类结肠癌细胞系DLD1染色体稳定性的影响.方法:建立四环素调控的Cyclin E稳定表达的细胞系DLD1tTA—Cyclin E.Western blot检测Cyclin E表达.Cyclin E持续稳定表达1,3,5,7和14 d后,对细胞进行DAPI染色,在荧光显微镜下计数CIN细胞的百分比.结果:Western blot显示,Cyclin E表达在96 h后达最高峰.Cyclin E表达关闭的DLD1细胞中.CIN细胞的百分比波动在0.97%-1.22%之间(t =3.81,P>0.01);而Cyclin E持续表达1,3,5,7和14 d后的DLD1细胞中,CTN细胞的百分比分别为2.41%,3.63%,3.92%,6.17%和8.34%(t= 4.77,P<0.01).结论:Cyclin E的表达失调可导致DLD1结肠癌细胞非整倍体数染色体的形成,也是造成结肠癌CIN的重要因素. AIM: To study the influence of stably inducible expression of Cyclin E on the chromosomal instability in human colon cancer cell line DLD1.METHODS : Tetracycline-responsive geneinducible cell line DLD1tTA-cyclin E was generated. Western blot was used to examine the induction of Cyclin E expression upon removal of doxycycline. 4'-6-Diamidino-2-phenylindole (DAPI) staining was performed to detect the percentage of cells with chromosomal instability 1, 3, 5, 7 and 14 d after the induction of Cyclin E expression.RESULTS: Western blot showed that the peak of Cyclin E expression appeared 96 h after induction. The percentage of cells with chromosomal instability in tet-off DLD1tTA-Cyclin E cells ranged from 0.97% to 1.22% (t = 3.81, P 〉 0.01). However, the percentages of cells with chromosomal instability were 2.41%, 3.63%, 3.92%, 6.17% and 8.34%, respectively, 1, 3, 5, 7 and 14 d after the induction of Cyclin E expression (t = 4.77, P 〈 0.01).CONCLUSION: Deregulation of cyclin E can induce the formation of aneuploidy in human colon cancer cell line DLD1, and it also plays an important role in the pathway of chromosomal instability.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第22期2164-2168,共5页 World Chinese Journal of Digestology
基金 国家高科技研究发展计划 No.2001AA218051
关键词 CYCLIN E 人类结肠癌 CIN Cyclin E Human colon cancer Chromosomal instability
  • 相关文献

参考文献33

  • 1Kashida H, Kudo SE. Early colorectal cancer: concept, diagnosis, and management. Int J Clin Oncol 2006; 11:1-8.
  • 2Wang WS, Chen PM, Su Y. Colorectal carcinoma: from tumorigenesis to treatment. Cell Mol Life Sci 2006; 63:663-671.
  • 3Hung KE, Chung DC. Colorectal cancer screening: today and tomorrow. South Med J 2006; 99: 240-246;quiz 247-249.
  • 4Kiesslich R, Hoffman A, Neurath MF. Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods. Endoscopy 2006; 38:5-10.
  • 5Harford WV. Colorectal cancer screening and surveillance. Surg Oncol Clin N Am 2006; 15:1-20.
  • 6Jeter JM, Kohlmann W, Gruber SB. Genetics of colorectal cancer. Oncology (Williston Park) 2006; 20:269-276; discussion 285-286, 288-289.
  • 7Vanhoefer U. Molecular mechanisms and targeting of colorectal cancer. Semin Oncol 2005; 32:7-10.
  • 8Anthony T. Colorectal cancer follow-up in 2005. Surg Oncol Clin N Am 2006; 15:175-193.
  • 9Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am 2006; 15:129-146.
  • 10Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 2004; 149:309-334.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部